TTY Biopharm Company Limited
4105
Rank in Stocks
#10965
TTY Biopharm Company Limited, along with its associated entities, specializes... TTY Biopharm Company Limited, along with its associated entities, specializes in the creation and distribution of pharmaceutical and chemical products across Taiwan and global markets. Its operations are structured into several key divisions: Oncology, Intensive Care, Healthcare, Export & CDMO, and an "Other" Business Unit. For anti-cancer and supportive therapies, the company markets a range of oncology medications under prominent brand names such as Lipo-Dox, Lonsurf, UFUR, TS-1, Pexeda, Gemmis, Oxalip, Irino, Epicin, Tynen, Anazo, Folina, Thado, Andason, Ivic, Asadin, Leavdo, Painkyl, Megest, Episil, Otril, Zobonic, Yondelis, and Pemazyre. Addressing infectious diseases and influenza, TTY Biopharm supplies anti-infection drugs including Brosym, Colimycin, Cubicin, Lipo-AB, Agrippal, Cepiro, Flusine, Maxtam, Metacin, and Flucelvax. Furthermore, the firm offers various healthcare-related pharmaceuticals designed for the digestive system, osteoporosis, and metabolic conditions, marketed under brands like Algitab, Alginos, Alginos Fresh, Bio-Cal Plus, and Sulfin. Beyond pharmaceuticals, the company is also involved in distributing functional foods, conducting international trade (import/export), and engaging in investment ventures. Established in 1960, TTY Biopharm maintains its principal office in Taipei, Taiwan.
Share Price
$2.50
Last synced: 2026-11-10
Market Cap
$622.31M
Change (1 day)
0.98%
Change (1 year)
-0.68%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade TTY Biopharm Company Limited (4105)
Category
Healthcare
Operating Margin for TTY Biopharm Company Limited (4105)
Operating Margin as of November 2026 TTM: 27.99%
According to TTY Biopharm Company Limited's latest financial reports, its current operating margin (TTM) is 27.99%. At the end of 2025 the company had an operating margin of 26.41%.
Operating Margin history for TTY Biopharm Company Limited from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 27.99% | 5.98% |
| 2025 | 26.41% | 11.67% |
| 2024 | 23.65% | -5.32% |
| 2023 | 24.98% | 2.63% |
| 2022 | 24.34% | -0.81% |
| 2021 | 24.54% | -14.49% |
| 2020 | 28.70% | 4.14% |
| 2019 | 27.56% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -99.31% |
DE
|
|
| 19.68% | -99.30% |
DE
|
|
| 13.26% | -99.53% |
JP
|
|
| 17.08% | -99.39% |
CH
|
|
| 14.92% | -99.47% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about TTY Biopharm Company Limited's operating margin
What is TTY Biopharm Company Limited's operating margin?
TTY Biopharm Company Limited's operating margin is 27.99%, as of Nov 2026.
What was TTY Biopharm Company Limited's operating margin in 2025?
In 2025, TTY Biopharm Company Limited's operating margin was 26.41%, compared with 23.65% in 2024.
How has TTY Biopharm Company Limited's operating margin changed since 2020?
From 2020 to 2025, TTY Biopharm Company Limited's operating margin was highest in 2020 (28.70%) and lowest in 2024 (23.65%).
How does TTY Biopharm Company Limited's operating margin compare with similar companies?
TTY Biopharm Company Limited's operating margin (27.99%) is higher than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.